Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06621329 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jul 2026 → Jul 2027
See other at-risk trials from University of California, Davis

Record History

  1. Primary completion pushed from Jul 2026 to Jul 2027
    • Study completion pushed from Oct 2026 to Oct 2027
    v5
  2. Re-verified, no change to tracked fieldsv4
  3. Start date changed from estimate of Oct 2024 to Oct 17, 2024v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication for reducing headache severity in patients with acute subarachnoid hemorrhage (aSAH). The study also examines whether this intervention can reduce opioid requirements during hospitalization and upon discharge.
Trial Details
NCT Number NCT06621329
Lead Sponsor University of California, Davis
Collaborators: Agnes Marshall Walker Foundation
Conditions
(from sponsor)		 SAH (Subarachnoid Hemorrhage), Headache
Related terms Headache, Subarachnoid Hemorrhage
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov